Insulins in equine urine: Qualitative analysis by immunoaffinity purification and liquid chromatography/tandem mass spectrometry for doping control purposes in horse-racing

Rapid Communications in Mass Spectrometry

Volumn 22, Issue 3, 2008, Pages 355-362

  Kuuranne, Tiia ^a,b   Thomas, Andreas ^a   Leinonen, Antti ^b   Delahaut, Philippe ^c   Bosseloir, Alan ^d   Schänzer, Wilhelm ^a   Thevis, Mario ^a  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

^b Yhtyneet Laboratoriot Oy   (Finland)

^c Centre d'Economie Rurale   (Belgium)

^d Zentech SA   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AFFINITY CHROMATOGRAPHY; CHAINS; INSULIN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PATIENT TREATMENT; PHASE SEPARATION; PURIFICATION; RECOMBINANT PROTEINS; SPORTS; SULFUR COMPOUNDS;

CONTROL PURPOSE; DOPING CONTROL; HUMAN INSULINS; IMMUNOAFFINITY; INSULIN ANALOGUES; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; PEPTIDE HORMONES; PRODUCT IONS; QUALITATIVE ANALYSIS;

PEPTIDES;

EID: 38949163071     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.3360     Document Type: Article

References (22)

1. Heise T, Heinemann L. Curr. Pharmaceut. Design 2001; 7: 1303.
2. Bolli GB, Di Marchi RD, Park GD, Pramming S, Koivisto VA. Diabetologia 1999; 42: 1151.
3. Kurtzhals P, Schäffer L, Sørensen A, Kristensen C, Jonassen I, Schmid C, Trüb T. Diabetes 2000; 49: 999.
4. Campbell RK, White JR, Levien T, Baker D. Clin. Therapeut. 2001; 23: 1938.
5. Harris P, Bailey SR, Elliot J, Longland A. J. Nutr. 2006; 136: 2114S.
6. Treiber KH, Kronfeld DS, Geor RJ. J. Nutr. 2006; 136: 2094S.
7. Sönksen PH. J. Endocrinol. 2001; 170: 13.
8. Trethewey J. J. Pharmaceut. Biomed. Anal. 1989; 7: 189.
9. Chevenne D, Trivin F, Porquet D. Diabetes Metab. 1999; 25: 459.
10. Shen H, Aspinwall CA, Kennedy RT. J. Chromatogr. B 1997; 689: 295.
11. Tao L, Kennedy RT. Anal. Chem. 1996; 68: 3899.
12. Khaksa G, Nalini K, Bhat M, Udupa N. Anal. Biochem. 1998; 260: 92.
13. Visser NFC, Lingeman H, Irth H. J. Pharmaceut. Biomed. Anal. 2003; 32: 295.
14. Kippen AD, Cerini F, Vadas L, Stöcklin R, Vu L, Offord RE, Rose K. J. Biol. Chem. 1997; 272: 12513.
15. Owen WE, Roberts WL. Clin. Chem. 2004; 50: 257.
16. Darby SM, Miller ML, Allen RO, LeBeau M. J. Anal. Toxicol. 2001; 25: 8.
17. Fierens C, Stöckl D, Thienpont LM, De Leenheer AP. Rapid Commun. Mass Spectrom. 2001; 15: 1433.
18. Thevis M, Thomas A, Delahaut P, Bosseloir A, Schänzer W. Anal. Chem. 2005; 77: 3579.
19. Deberg M, Houssa P, Frank BH, Sodoyez-Goffaux F, Sodoyez JC. Clin. Chem. 1998; 44: 1504.
20. Thevis M, Thomas A, Delahaut P, Bosseloir A, Schänzer W. Anal. Chem. 2006; 78: 1897.
21. Thomas A, Thevis M, Delahaut P, Bosseloir A, Schänzer W. Anal. Chem. 2007; 79: 2518.
22. Thevis M, Loo JA, Ogorzalek Loo RR, Schänzer W. Rapid Commun. Mass Spectrom. 2007; 21: 297.